{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:14Z","timestamp":1792664594489,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014173","name":"Health and Family Planning Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["SZSM202011017"],"award-info":[{"award-number":["SZSM202011017"]}],"id":[{"id":"10.13039\/501100014173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014173","name":"Health and Family Planning Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["SZSM202411003"],"award-info":[{"award-number":["SZSM202411003"]}],"id":[{"id":"10.13039\/501100014173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217793","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T19:05:27Z","timestamp":1747076727000},"page":"217793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research"],"prefix":"10.1016","volume":"625","author":[{"given":"Ruici","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6635-187X","authenticated-orcid":false,"given":"Weiren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217793_bib1","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2025.217793_bib2","first-page":"221","article-title":"[Cancer incidence and mortality in China, 2022]","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"10.1016\/j.canlet.2025.217793_bib3","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.217793_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.urolonc.2017.10.014","article-title":"Neoadjuvant treatment for muscle-invasive bladder cancer: the past, the present, and the future","volume":"36","author":"Hermans","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.canlet.2025.217793_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrurol.2017.179","article-title":"Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy","volume":"15","author":"Felsenstein","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2025.217793_bib7","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1038\/s41598-022-09438-9","article-title":"Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time","volume":"12","author":"Xu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217793_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41467-017-02320-7","article-title":"Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071795","article-title":"Molecularly targeted therapy towards genetic alterations in advanced bladder cancer","volume":"14","author":"Thomas","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217793_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2021.12.004","article-title":"Genomic features of muscle-invasive bladder cancer arising after prostate radiotherapy","volume":"81","author":"Mossanen","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217793_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.950241","article-title":"The origin and evolution of bladder cancer stem cells","volume":"10","author":"Tan","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217793_bib14","article-title":"identification-molecular-characterization-clinical-prognosis-and-therapeutic-targeting-of-human-bladder","author":"Chan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217793_bib15","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1073\/pnas.1120605109","article-title":"Three differentiation states risk-stratify bladder cancer into distinct subtypes","volume":"109","author":"Volkmer","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217793_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2012.02.010","article-title":"Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer","volume":"322","author":"Zhang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217793_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1349-7006.2009.01414.x","article-title":"Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples","volume":"101","author":"Bentivegna","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217793_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/07357900801941845","article-title":"Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells","volume":"26","author":"Yang","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2025.217793_bib19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/stem.92","article-title":"Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma","volume":"27","author":"He","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2025.217793_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/stem.1625","article-title":"A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors","volume":"32","author":"Dancik","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2025.217793_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ncb2956","article-title":"Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma","volume":"16","author":"Shin","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217793_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/ncb3038","article-title":"Bladder cancers arise from distinct urothelial sub-populations","volume":"16","author":"Van Batavia","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217793_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217793_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11914","article-title":"KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis","volume":"7","author":"Papafotiou","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1158\/0008-5472.CAN-17-0836","article-title":"YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells","volume":"78","author":"Ooki","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217793_bib27","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: a tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217793_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-020-3034-x","article-title":"Creation of bladder assembloids mimicking tissue regeneration and cancer","volume":"588","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217793_bib29","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-021-25103-7","article-title":"An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer","volume":"12","author":"Gouin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib30","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","article-title":"Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217793_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib32","article-title":"Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2025.217793_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.1951","article-title":"Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche","volume":"15","author":"Ootani","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217793_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217793_bib35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2025.217793_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217793_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib39","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","article-title":"Bladder cancer organoids as a functional system to model different disease stages and therapy response","volume":"14","author":"Minoli","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib40","article-title":"Establishment of three-dimensional bioprinted bladder cancer-on-a-chip with a microfluidic system using Bacillus calmette-guerin","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217793_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4111\/icu.20210425","article-title":"Immunotherapeutic effects of recombinant Bacillus Calmette-Guerin containing sic gene in ex vivo and in vivo bladder cancer models","volume":"63","author":"Kim","year":"2022","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4111\/icu.20220293","article-title":"Efficacy of recombinant Bacillus Calmette-Guerin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model","volume":"64","author":"Choi","year":"2023","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007949","article-title":"Bioengineering approaches for the advanced organoid research","volume":"33","author":"Yi","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2025.217793_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccell.2014.09.001","article-title":"Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors","volume":"26","author":"Shin","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2016.45","article-title":"Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1","volume":"2","author":"McNiel","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217793_bib46","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib47","article-title":"Patient-derived immunocompetent tumor organoids: a platform for chemotherapy evaluation in the context of T-cell recognition","volume":"63","author":"Zhao","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2025.217793_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coph.2021.08.008","article-title":"Preclinical pharmacology modeling of chimeric antigen receptor T therapies","volume":"61","author":"Kumari","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217793_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1248","article-title":"Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro","volume":"10","author":"Yu","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.canlet.2025.217793_bib50","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JCM.05852-11","article-title":"Evidence of uncultivated bacteria in the adult female bladder","volume":"50","author":"Wolfe","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.canlet.2025.217793_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.canlet.2025.217793_bib53","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217793_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.urology.2018.12.034","article-title":"The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics","volume":"126","author":"Bajic","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2025.217793_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124488","article-title":"Urobiome in gender-related diversities of bladder cancer","volume":"21","author":"Bilski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217793_bib56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: an exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.canlet.2025.217793_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09851","article-title":"Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder","volume":"472","author":"Shin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217793_bib58","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/2159-8290.CD-22-0201","article-title":"Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer","volume":"12","author":"Goubet","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217793_bib59","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","article-title":"Intestinal organoid cocultures with microbes","volume":"16","author":"Puschhof","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2025.217793_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijc.10140","article-title":"Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation","volume":"98","author":"Dangles","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib61","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217793_bib62","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibtech.2017.12.005","article-title":"Personalized cancer medicine: an organoid approach","volume":"36","author":"Es","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.canlet.2025.217793_bib65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217793_bib66","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncb3047","article-title":"Single luminal epithelial progenitors can generate prostate organoids in culture","volume":"16","author":"Chua","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217793_bib67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib68","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.scib.2023.11.027","article-title":"Engineering redirected NF-kappaB\/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer","volume":"68","author":"Zheng","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.canlet.2025.217793_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41416-023-02494-6","article-title":"Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation","volume":"130","author":"Viergever","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib70","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","article-title":"3D bioprinting of tissues and organs","volume":"32","author":"Murphy","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2025.217793_bib71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.actbio.2019.06.017","article-title":"3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels","volume":"95","author":"Mollica","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2025.217793_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2015.12.071","article-title":"3D printing in pharmaceutics: a new tool for designing customized drug delivery systems","volume":"499","author":"Jonathan","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2025.217793_bib73","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab9491","article-title":"Use of inkjet-printed single cells to quantify intratumoral heterogeneity","volume":"12","author":"Yoon","year":"2020","journal-title":"Biofabrication"},{"key":"10.1016\/j.canlet.2025.217793_bib74","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ac6d11","article-title":"Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling","volume":"14","author":"Shukla","year":"2022","journal-title":"Biofabrication"},{"key":"10.1016\/j.canlet.2025.217793_bib75","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217793_bib76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-pathol-012414-040418","article-title":"Engineered in vitro disease models","volume":"10","author":"Benam","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2025.217793_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701000","article-title":"Multiorgan microphysiological systems for drug development: strategies, advances, and challenges","volume":"7","author":"Wang","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2025.217793_bib78","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acs.analchem.8b05293","article-title":"Recent advances in body-on-a-chip systems","volume":"91","author":"Sung","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.canlet.2025.217793_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2022.10.001","article-title":"Microfluidic organoids-on-a-chip: the future of human models","volume":"144","author":"Saorin","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217793_bib80","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.apsb.2023.02.006","article-title":"Emerging trends in organ-on-a-chip systems for drug screening","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2025.217793_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/0008-5472.CAN-19-0342","article-title":"An engineered tumor-on-a-chip device with breast cancer-immune cell interactions for assessing T-cell recruitment","volume":"80","author":"Aung","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217793_bib82","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2015.12.003","article-title":"Microfluidics: a new tool for modeling cancer-immune interactions","volume":"2","author":"Boussommier-Calleja","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib83","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.canlet.2025.217793_bib84","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1039\/C9LC00496C","article-title":"A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity","volume":"19","author":"Jung","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.canlet.2025.217793_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19058-4","article-title":"Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids","volume":"11","author":"Schuster","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib86","article-title":"3D bioprinted organ\u2010on\u2010chips","volume":"4","author":"Rahmani Dabbagh","year":"2022","journal-title":"Aggregate"},{"key":"10.1016\/j.canlet.2025.217793_bib87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrurol.2014.129","article-title":"Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer","volume":"11","author":"Choi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib89","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010","article-title":"Genetic alterations in the molecular subtypes of bladder cancer: illustration in the cancer genome Atlas dataset","volume":"72","author":"Choi","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib90","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217793_bib91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.217793_bib92","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217793_bib93","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.21873\/anticanres.13219","article-title":"Bladder organoids and spheroids: potential tools for normal and diseased tissue modelling","volume":"39","author":"Vasyutin","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217793_bib94","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ijc.26475","article-title":"Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells","volume":"131","author":"Tatokoro","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib95","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41416-019-0609-0","article-title":"Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies","volume":"121","author":"Kita","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217793_bib96","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1111\/cas.15051","article-title":"Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer","volume":"112","author":"Murakami","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217793_bib97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41698-023-00466-w","article-title":"Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer","volume":"7","author":"Garioni","year":"2023","journal-title":"npj Precis. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:34:46Z","timestamp":1762288486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352500360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":97,"alternative-id":["S030438352500360X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217793","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217793"}}